Drug Shortage Report for JAMP RABEPRAZOLE

Last updated on 2025-01-23 History
Report ID 204047
Drug Identification Number 02415291
Brand name JAMP RABEPRAZOLE
Common or Proper name Rabeprazole Sodium Delayed Release Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-08
Estimated end date 2025-10-31
Actual end date
Shortage status Actual shortage
Updated date 2025-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2025-01-23 French Compare
v23 2025-01-23 English Compare
v22 2024-10-03 French Compare
v21 2024-10-03 English Compare
v20 2024-08-05 French Compare
v19 2024-08-05 English Compare
v18 2024-07-29 French Compare
v17 2024-07-29 English Compare
v16 2024-06-03 French Compare
v15 2024-06-03 English Compare
v14 2024-04-29 French Compare
v13 2024-04-29 English Compare
v12 2024-03-11 French Compare
v11 2024-03-11 English Compare
v10 2024-02-06 French Compare
v9 2024-02-06 English Compare
v8 2023-12-18 French Compare
v7 2023-12-18 English Compare
v6 2023-11-15 French Compare
v5 2023-11-15 English Compare

Showing 1 to 20 of 24